Mr. Brinkley owns and operates several companies in the aerospace and biotechnology markets. Currently, Mr. Brinkley holds Board Seats at L2 Solutions, ChemoSen3d and actively serves on the Omnidermal USA management team as a Co-founding member. Additionally, Chad is the Co-founder of ProXopS that provides system engineering services, space product development and technology investment consulting.